Solid Biosciences Inc. SLDB
$7.20
▼ -1.11% 24H
About
Solid Biosciences Inc. is a precision genetic medicine company developing gene therapies for rare neuromuscular and cardiac diseases. Its lead candidate, SGT-003, targets Duchenne muscular dystrophy and is in phase 1/2 clinical trials. The company advances a diversified pipeline including SGT-212 for Friedreich's ataxi…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees121
TickerSLDB
Statistics
Market Cap$708.4M
Revenue (TTM)—
Net Income-$174.3M
Net Margin—
EPS$-1.99
P/E0.15
P/S—
P/B1.90
EV/EBITDA-1.80
ROE-57.4%
Dividend Yield—
Price$7.20
Data: Twelve Data · Revenue = mcap / P/S